Mutations in gyrase and topoisomerase genes associated with fluoroquinolone resistance in Salmonella serovars from retail meats

Food Research International

Volumn 45, Issue 2, 2012, Pages 935-939

  Yang, Baowei ^a   Xi, Meili ^a   Cui, Shenghui ^b   Zhang, Xiuli ^c   Shen, Jinling ^a   Sheng, Min ^a   Qu, Dong ^a   Wang, Xin ^a   Meng, Jianghong ^a,d  

^a NORTHWEST A F UNIVERSITY   (China)

^b State Food and Drug Administration   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

DNA gyrase; Mutations; Quinolone and fluoroquinolone resistance; Salmonella; Topoisomerase IV

Indexed keywords

CIPROFLOXACIN; DNA GYRASES; DNA SEQUENCING ANALYSIS; DOUBLE MUTATION; FLUOROQUINOLONES; MINIMUM INHIBITORY CONCENTRATION; MUTATIONS; POINT MUTATIONS; QUINOLONES; SINGLE MUTATION; TOPOISOMERASES;

GENES; POLYMERASE CHAIN REACTION;

SALMONELLA;

SALMONELLA;

EID: 84857391761     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2011.01.031     Document Type: Article

References (36)

1. Acar J.F., Goldstein F.W. Trends in bacterial resistance to fluoroquinolones. Clinical Infectious Diseases 1997, 24:67-73.
2. Ahmed D., D'Costa L.T., Alam K., Nair G.B., Hossain M.A. Multidrug-resistant Salmonella enterica serovar Typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh. Antimicrobial Agents and Chemotherapy 2006, 50:3516-3517.
3. Baucheron S., Chaslus-Dancla E., Cloeckaert A., Chiu C.H., Butaye P. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovars Schwarzengrund isolates from humans in Taiwan. Antimicrobial Agents and Chemotherapy 2005, 49:862-863.
4. Baucheron S., Imberechts H., Chaslus-Dancla E., Cloeckaert A. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microbial Drug Resistance 2002, 8:281-289.
5. Bhan M.K., Bhal R., Bhatnagar S. Typhoid and paratyphoid fever. Lancet 2005, 366:749-762.
6. Brown N.M., Millar M.R., Frost J.A., Rowe B. Ciprofloxacin resistance in Salmonella paratyphi A. The Journal of Antimicrobial Chemotherapy 1994, 33:1258-1259.
7. Casin I., Breuil J., Darchis J.P., Guelpa C., Collatz E. Fluoroquinolone resistance linked to gyrA, gyrB and parC mutations in Salmonella enterica Typhimurium isolates in humans. Emerging Infectious Diseases 2003, 9:1455-1457.
8. Chu Y.W., Houang E.T.S., Cheng A.F.B. Novel combination of mutations in the DNA gyrase and topoisomerase IV Genes in laboratory-grown fluoroquinolone-resistant Shigella flexneri mutants. Antimicrobial Agents and Chemotherapy 1998, 42:3051-3052.
9. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. CLSI document M7-A2 2003, Clinical and Laboratory Standards Institute, Wayne, PA. 2nd ed.
10. Cloeckaert A., Chaslus-Dancla E. Mechanism of quinolone resistance in Salmonella. Veterinary Research 2001, 32:291-300.
11. Cui S., Li J., Sun Z., Hu C., Jin S., Guo Y., et al. Ciprofloxacin-resistant Salmonella enteric serotype typhimurium, China. Emerging Infectious Diseases 2008, 14:493-495.
12. Dimitrov T., Dashti A.A., Albaksami O., Udo E.E., Jadaon M.M., Albert M.J. Ciprofloxacin-resistant Salmonella enteric serovar Typhi from Kuwait with novel mutations in gyrA and parC genes. Journal of Clinical Microbiology 2009, 47:208-211.
13. Eaves D.J., Randall L., Gray D.T., Buckley A., Woodward M.J., White A.P., et al. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrobial Agents and Chemotherapy 2004, 48:4012-4015.
14. Everett M.J., Jin Y.F., Ricci V., Piddock L.J.V. Contribution of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrobial Agents and Chemotherapy 1996, 40:2380-2386.
15. Fournier B., Hooper D.C. Mutations in topoisomerase IV and DNA-Gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and cumarin activity. Antimicrobial Agents and Chemotherapy 1998, 42:121-128.
16. Gaind R., Paglietti B., Murgia M., Dawar R., Uzzau S., Cappuccinelli P., et al. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. The Journal of Antimicrobial Chemotherapy 2006, 58:1139-1144.
17. Giraud E., Baucheron S., Cloeckaert A. Resistance to fluoroquinolones in Salmonella: Emerging mechanisms and resistance prevention strategies. Microbes and Infection 2006, 8:1937-1944.
18. Hakanen A., Kotilainen P., Huovinen P., Helenius H., Siitonen A. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerging Infectious Diseases 2001, 7:996-1003.
19. Hiasa H. The Glu-84 of the parC subunit plays critical roles in both topoisomerase IV-quinolone and topoisomerase IV-DNA interactions. Biochemistry 2002, 41:11779-11785.
20. Hirose K.A., Hashimoto A., Tamura K., Kawamura Y., Ezaki T., Sagara H., et al. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enteric serovar Typhi and serovar Paratyphi A. Antimicrobial Agents and Chemotherapy 2002, 46:3249-3252.
21. Hooper D.C. Mechanisms of fluoroquinolones resistance. Emerging Infectious Diseases 2001, 7:337-341.
22. Hopkins K.L., Davies R.H., Threlfall E.J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent development. International Journal of Antimicrobial Agents 2005, 25:358-373.
23. Ince D., Hooper D.C. Mechanisms and frequency of resistance to gatifloxacin in comparison to AM1121 and ciprofloxacin in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2001, 45:2755-2764.
24. Izumiya H., Mori K., Kurazono T., Yamaguchi M., Higashide M., Konishi N., et al. Characterization of isolates of Salmonella enterica serovar Typhimurium displaying high-level fluoroquinolone resistance in Japan. Journal of Clinical Microbiology 2005, 43:5074-5079.
25. Ling J.M., Chan E.W., Lam A.W., Cheng A.F. Mutations in topoisomerase genes of fluoroquinolone-resistant Salmonellae in Hong Kong. Antimicrobial Agents and Chemotherapy 2003, 47:3567-3573.
26. Murray A., Coia J.E., Mather H., Brown D.J. Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003. The Journal of Antimicrobial Chemotherapy 2005, 56:110-114.
27. Piddock L.J., Ricci V., McLaren I., Griggs D.J. Role of mutations in gyrA and parC genes in nalidixic-acid-resistant Salmonella serotypes isolated from animals in the United Kingdom. The Journal of Antimicrobial Chemotherapy 1998, 41:635-641.
28. Ribot E.M., Fair M.A., Gautom R., Cameron D.N., Hunter S.B., Swaminathan B., et al. Standardization of pulsed-field gel electrophoresis protocols for the subtying of Escherichia coli O157:H7, Salmonella, and Shiglla for PulseNet. Foodborne Pathogens and Disease 2006, 3:59-67.
29. Ruiz J., Casellas S., Jimenez de Anta M.T., Vila J. The region of the parE gene, homologous to the quinolone-resistant determing region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates. The Journal of Antimicrobial Chemotherapy 1997, 39:838-840.
30. Schmitz F.J., Jones M.E., Hofmann B., Hansen B., Scheuring S., Luckefar M., et al. Characterization of grlA, grlB, gyrA and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrobial Agents and Chemotherapy 1998, 42:1249-1252.
31. Singh S., Yadav A.S., Singh S.M., Bharti P. Prevalence of Salmonella in chicken eggs collected from poultry farms and marketing channels and their antimicrobial resistance. Food Research International 2010, 43:2027-2030.
32. Solnik-Isaac H., Weinberger M., Tabak M., Ben-David A., Shachar D., Yaron S. Quinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: Evidence for clonal expansion. Journal of Clinical Microbiology 2007, 45:2575-2579.
33. Wang L., Shi L., Alam M.J., Geng Y., Li L. Specific and rapid detection of foodborne Salmonella by loop-mediated isothermal amplification method. Food Research International 2008, 41:69-74.
34. White D.G., Zhao S., Sudler R., Ayers S., Friedman S., Chen S., et al. The isolation of antibiotic-resistant Salmonella from retail ground meats. N England J Med. 2001, 345:1147-1154.
35. Yang B., Zheng J., Brown E.W., Zhao S., Meng J. Characterisation of antimicrobial resistance associated integrons and mismatch repair gene mutations in Salmonella serotypes. International Journal of Antimicrobial Agents 2009, 33:120-124.
36. Yang B., Qu D., Shen J., Xi M., Zhi S., Cui S., et al. Antimicrobial susceptibility and related genes of Salmonella serovars from retail food in Shaanxi Province. Acta Microbiogica Sinica 2010, 50:788-796.